Sean Berry, PhD

Sean Berry, PhD

Pictured: Sean Berry, PhD

I am an assistant attending physicist in the External Beam Treatment Planning section of the Clinical Physics Service. I am responsible for implementing new radiotherapy software tools in the clinic.

My research interests are focused on improving the efficiency and accuracy of the radiotherapy treatment planning and delivery process. I also have an interest in the medical physics education of physicians, radiation therapists, and fellow physicists. I am an editor for the Raphex examination, a test administered to radiation oncology residents in the US that measures knowledge of radiological physics concepts.

I received a PhD in medical physics from Columbia University in 2012. I was certified in therapeutic radiological physics by the American Board of Radiology in 2008 and am a member of the American Association of Physicists in Medicine, the Radiological and Medical Physics Society of New York, and the American Society for Radiation Oncology.


Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Sean Berry discloses the following relationships and financial interests:

No disclosures meeting criteria for time period

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures